Hartis-Pharma SA
Hartis-Pharma SA, public limited company in Nyon (VD), research. Registration active in the commercial register since 2016. UID CHE-293.248.994.
HARTIS Pharma is a Swiss biotech focusing on unmet or inadequately addressed medical needs by revisiting the therapeutic potential of high-density lipoprotein (HDL). It aims to develop treatments for diseases and complications associated with decreased HDL functions, including Sickle Cell Disease.1
Commercial register
- Legal form
- Public limited company
- Registered office
- Chemin de Bonmont 13 C, 1260 Nyon
- Share capital
- CHF 100,000
- UID
- CHE-293.248.994
- Registered since
- 2016
- Registered purpose (original language)
- la société a pour but la recherche et le développement de traitements des pathologies bénéficiant des fonctions et propriétés des lipoprotéines de haute densité (HDL) (pour but complet cf. statuts).
Similar companies
- PPRI SA Chêne-Bougeries Real estate activities
- GENFA GLOBAL LB (LABORATOIRES BIOPHARMACEUTIQUES) SA Le Grand-Saconnex
- TRB CHEMEDICA INTERNATIONAL SA Carouge (GE) Wholesale trade
- Gliapharm SA Genève Scientific research and development
- Endotelix Diagnostics Sàrl Genève Human health activities
- Servier (Suisse) SA Genève Manufacture of basic pharmaceutical products
A free account opens every company that looks like Hartis-Pharma SA, and what they have in common. Create a free account
1 This information was estimated by machine learning and may contain errors.